Mesoblast

Industry Lists

Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine.

The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells.

The company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of commercial products and late-stage product candidates.

Contact Details

Level 38, 55 Collins Street, MELBOURNE VIC 3000

03 9639 6036

info@mesoblast.com

www.mesoblast.com

Lists and Charts

Share Price

Closing price for the last 90 trading days

View Full Chart

Share Transactions

12/04/24

$200k Bought

Jane Bell

10/01/24

$0 Issued

William Burns

10/01/24

$0 Issued

Eric Rose

Total value as at the date of the transaction

Revenue

Rank	Company	Revenue
754^th	Mesoblast	$13.3m
875^th	Recce Pharmaceuticals	$4.4m
877^th	Immutep	$4.3m
880^th	Love Group Global	$4.0m
881^st	Alterity Therapeutics	$3.9m

View Full List

1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®

Total Shareholder Return as at 29/02/24

Rank	Company	1 yr	5 yr
88^th	Love Group Global	100%	-5%
192^nd	Immutep	54%	4%
1030^th	Recce Pharmaceuticals	-21%	26%
1389^th	Alterity Therapeutics	-45%	-34%
1728^th	Mesoblast	-68%	-24%

1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Collapse All Lists and Charts

Company Activity

	NEW ROLE: Eric Rose, Executive Director, Chief Medical Officer	21 Apr 2022
	NEW ROLE: Philip Krause, Non-Executive Director	21 Apr 2022
	NEW ROLE: Philip Facchina, Non-Executive Director	13 Apr 2021
	NEW ROLE: Paul Hodgkinson,	24 Nov 2020
	NEW ROLE: Josh Muntner, Chief Financial Officer	24 Nov 2020
	REMUNERATION UPDATE: Joseph Swedish, Non-Executive Director, Chair since 2019	13 Nov 2020
	REMUNERATION UPDATE: Donal O'Dwyer, Non-Executive Director	13 Nov 2020
	REMUNERATION UPDATE: William Burns, Non-Executive Director, Vice Chair since 2016	13 Nov 2020
	REMUNERATION UPDATE: Michael Spooner, Non-Executive Director	13 Nov 2020